DALLAS, TX & LAKELAND, TN – [Date of Publication] – In a move set to redefine the landscape of patient care in orthotics, prosthetics, and complex rehabilitation technology, Hanger Inc., a leading provider of orthotic and prosthetic (O&P) patient care services, has announced its acquisition of Numotion, a prominent provider of complex rehabilitation technology (CRT) and mobility products. This strategic combination will create "Hanger Numotion," a formidable North American platform poised to serve over 1.5 million patients annually across the United States and Canada. The transaction, structured as a cash acquisition of Numotion by Hanger, is expected to close in the fourth quarter of 2026 and will result in a combined entity controlled by Patient Square Capital.
This merger brings together two industry giants with complementary capabilities, promising to enhance access to care, foster innovation, and invest significantly in clinicians, ultimately improving the lives of individuals seeking greater mobility and independence.
A New Giant in Mobility and Rehabilitation Emerges
The announcement of Hanger’s acquisition of Numotion marks a pivotal moment for the rehabilitative care sector in North America. The newly formed entity, "Hanger Numotion," is not merely a merger of two companies but a strategic alignment designed to create a comprehensive, scaled platform offering an unparalleled spectrum of services. Hanger, renowned for its extensive network of orthotic and prosthetic clinics, will integrate with Numotion, a leader in complex rehabilitation technology and mobility solutions.
The core services of the combined organization will span critical areas of patient need: orthotics and prosthetics (O&P), complex rehabilitation technology (CRT), and a broad array of mobility and independence solutions. This holistic approach aims to provide a seamless continuum of care for patients, addressing diverse mobility challenges from limb loss and musculoskeletal conditions to neurological disorders requiring specialized equipment.
The sheer scale of Hanger Numotion is impressive. Upon completion of the transaction, the combined enterprise will serve more than 1.5 million patients annually across the United States and Canada. This extensive reach will be supported by Hanger’s existing network of 925 U.S.-based O&P clinics and Numotion’s robust footprint of over 200 locations throughout North America. This geographic density and breadth of service offerings are expected to significantly expand access to high-quality rehabilitative care for a broader patient population.
Financially, the transaction is structured as Hanger acquiring Numotion for cash. Post-acquisition, the combined company will be controlled by Patient Square Capital, a healthcare-focused investment firm, underscoring the significant long-term growth potential identified within this integrated model. Both Hanger and Numotion will continue to operate under their established brands and maintain their respective clinical operations, a decision aimed at preserving brand recognition, existing patient relationships, and specialized expertise while leveraging the operational efficiencies and expanded resources of the larger organization.
Leadership for the new entity has also been confirmed, with Mike Swinford, the current CEO of Numotion, slated to become the CEO of the combined Hanger Numotion. This appointment signals a clear direction for the future, leveraging Swinford’s proven track record in scaling and diversifying a mobility-focused enterprise. Pete Stoy, the current CEO of Hanger Inc., will transition from his role, expressing confidence in Swinford’s leadership to guide the combined organization forward.
A Strategic Fusion: Unpacking the Rationale
The strategic rationale behind the Hanger Numotion merger is deeply rooted in the complementary nature of their respective services and the growing demand for integrated patient care solutions. This fusion is anticipated to unlock significant value for patients, clinicians, and the broader healthcare system.
Complementary Strengths and Synergies
Hanger has long been a pillar in the O&P community, providing custom-fabricated medical devices such as artificial limbs (prosthetics) and braces (orthotics) designed to restore function, improve mobility, and enhance the quality of life for individuals with various physical challenges. Their expertise lies in clinical assessment, custom fitting, and ongoing patient support for these specialized devices.
Numotion, on the other hand, specializes in Complex Rehabilitation Technology (CRT), which includes a range of individually configured manual and power wheelchairs, seating and positioning systems, and other adaptive equipment. These solutions are crucial for individuals with significant medical conditions or disabilities that require highly customized products and services to maximize their health, function, and independence. Numotion also provides a variety of general mobility products and services, further broadening its scope.
The synergy created by combining these two powerhouses is profound. Patients often require services from both O&P and CRT providers at different stages of their mobility journey, or even concurrently. For instance, an individual recovering from an amputation might first need a prosthetic limb (Hanger’s expertise) and later require a specialized wheelchair for specific activities or to manage other co-morbidities (Numotion’s expertise). By bringing these capabilities under one roof, Hanger Numotion can offer a truly full spectrum of care, streamlining the patient experience and ensuring more coordinated and holistic treatment plans. This integration can lead to better patient outcomes by facilitating smoother transitions between different types of care and ensuring that all aspects of a patient’s mobility needs are addressed comprehensively.
Geographically, the combination leverages Hanger’s strong U.S. clinic presence with Numotion’s extensive North American network, creating a robust, unified platform. This expanded footprint not only increases market penetration but also enhances service accessibility, especially in underserved regions.
Enhanced Access, Innovation, and Investment
The combined scale of Hanger Numotion will translate directly into greater resources, which are earmarked for several critical areas. Firstly, it promises to expand access to care. With a larger network and more integrated services, the new entity can reach more patients and offer a wider range of solutions under a single, coordinated framework. This is particularly important in an environment where healthcare access can be fragmented and challenging for individuals with complex needs.
Secondly, the merger will facilitate significant investment in clinicians. This includes enhanced training programs, access to cutting-edge technology, and opportunities for professional development. A well-resourced and highly skilled clinical workforce is paramount to delivering superior patient care, and the combined company’s financial strength is expected to support this commitment. Clinicians across both O&P and CRT disciplines will benefit from shared knowledge, best practices, and collaborative treatment models, potentially leading to more innovative solutions for patients.
Thirdly, the combined entity is poised to drive further product innovation. By pooling expertise and resources, Hanger Numotion can invest more robustly in research and development. This could lead to advancements in prosthetic and orthotic design, more sophisticated CRT solutions, and the development of integrated technologies that bridge the gap between different mobility aids. The insights gained from serving a diverse patient population of over 1.5 million individuals will provide invaluable data for identifying unmet needs and developing targeted, effective solutions. This focus on innovation is critical as technology continues to evolve, offering new possibilities for improving patient independence and quality of life.
Leadership Transition and Vision for the Future
The success of any major corporate integration hinges significantly on its leadership. The Hanger Numotion merger sees a strategic appointment at the helm, alongside a graceful transition for the outgoing CEO.
Mike Swinford: Steering the Combined Entity
Following the close of the transaction, Mike Swinford, the current CEO of Numotion, will assume the leadership role as CEO of the combined Hanger Numotion. Swinford brings a wealth of experience and a proven track record of success to this new position. He has led Numotion since 2014, during which time he is credited with transforming the business into a mobility industry leader. Under his guidance, Numotion achieved sustained growth, expanded its market presence, and diversified its service offerings, solidifying its position in the complex rehabilitation technology sector.
Prior to his tenure at Numotion, Swinford spent more than two decades at General Electric (GE), a company renowned for its operational excellence and leadership development. His extensive experience at GE included a significant role as President and CEO of GE Healthcare Services, a division that provided essential technology, services, and solutions to healthcare providers worldwide. This background in a large, diversified healthcare technology and services company positions him uniquely to navigate the complexities of integrating Hanger and Numotion and leading a scaled, multi-faceted organization.
Swinford articulated a clear vision for the combined entity, stating, “Our two companies share a fundamental belief in the role mobility can play in improving people’s lives. By bringing together our respective experience, capabilities, and passion to serve our customers and patients, we have an opportunity to build on each company’s strengths and help more people across their mobility journeys.” This statement underscores a patient-centric philosophy and a commitment to leveraging collective strengths to enhance the patient experience. He also extended gratitude to Pete Stoy for his leadership, AEA Investors for their partnership, and LLR for its long-standing investment in Numotion, signaling a collaborative and appreciative approach to the transition.
Pete Stoy’s Legacy at Hanger
Pete Stoy, the current CEO of Hanger Inc., will be stepping down from his role after the transaction closes. Stoy joined Hanger in 2020 and has since overseen a significant period of transformation and growth for the company. During his leadership, Hanger successfully built a stronger, more integrated national platform, making meaningful investments in its people, technology, and overall capabilities. These efforts have strategically positioned Hanger for sustained growth and enhanced its standing as a leader in orthotic and prosthetic patient care.
Stoy expressed immense pride in his team’s accomplishments and the evolution of Hanger under his leadership. He also conveyed strong confidence in Mike Swinford’s ability to lead the combined Hanger Numotion, stating, “I have worked with Mike closely throughout this process, and I have tremendous confidence in his ability to lead Hanger Numotion following the close of the transaction. He is an accomplished leader who shares our commitment to patients and our people, and I believe he is well-positioned to build on Hanger’s momentum and realize the tremendous potential of the combined organization ahead.” This endorsement highlights a smooth leadership transition and a shared strategic vision for the future of the combined enterprise.
Chronology of the Deal and Market Context
The journey towards the formation of Hanger Numotion represents a significant strategic decision rooted in the evolving dynamics of the rehabilitative care market and the ambitions of the respective entities and their financial partners.
The Road to Hanger Numotion
Hanger Inc. has a storied history as a foundational provider in the O&P space, with a legacy spanning well over a century. Over the years, it has grown through organic expansion and strategic acquisitions, building a vast network of clinics and a reputation for clinical excellence. Its consistent focus on patient outcomes and technological advancement has solidified its position in the market.
Numotion, while perhaps a more recent entrant in its current form, has rapidly ascended to become a leading provider of CRT and mobility solutions. Its growth has been significantly bolstered by its status as a portfolio company of AEA Investors, a prominent private equity firm. Private equity backing often provides companies with the capital and strategic guidance necessary for aggressive expansion and market consolidation, which has been evident in Numotion’s trajectory. LLR, another investment firm, has also been a longstanding investor in and supporter of Numotion.
The current transaction, where Hanger acquires Numotion for cash, is a testament to the strategic fit and perceived value of Numotion’s business within the broader rehabilitative care ecosystem. The control of the combined company by Patient Square Capital further underscores the financial community’s belief in the long-term potential of this integrated model. Patient Square Capital’s investment strategy is explicitly focused on the healthcare sector, indicating a deep understanding of the market and a commitment to fostering growth and innovation in the industry.
The expected closing date for the transaction is the fourth quarter of 2026. This extended timeline is typical for transactions of this magnitude and complexity, allowing for thorough regulatory reviews, including antitrust considerations, and the satisfaction of various "customary closing conditions." These conditions typically involve obtaining necessary approvals from regulatory bodies, securing financing, and ensuring compliance with legal and contractual obligations. The deliberate pace allows for careful planning and integration strategies to be developed well in advance of the official close.
A Dynamic Market Landscape
The market for orthotics, prosthetics, complex rehabilitation technology, and mobility solutions is dynamic and growing, driven by several macro trends. An aging global population is a primary driver, as older adults often require more rehabilitative services and mobility aids due to age-related conditions, chronic diseases, and increased incidence of falls. Concurrently, advances in medical science mean that more individuals are surviving traumatic injuries, congenital conditions, and chronic illnesses that necessitate long-term rehabilitative care.
The market is characterized by a mix of large national providers, regional players, and numerous independent clinics. While this fragmentation has historically allowed for specialized, localized care, there is a growing trend towards consolidation. Larger entities can achieve economies of scale, invest more heavily in technology and talent, and potentially offer more comprehensive services, which can be attractive to both patients and payers.
Technological advancements are also continually reshaping the industry. In O&P, innovations range from advanced materials and 3D printing for custom devices to sophisticated microprocessor-controlled prostheses that offer unprecedented levels of function. In CRT, developments include power wheelchairs with advanced controls, intelligent seating systems, and integrated smart home technologies that enhance independence. The Hanger Numotion merger is well-positioned to capitalize on these technological shifts by having the scale and resources to adopt and drive further innovation. The competitive environment, while robust, also presents opportunities for market leaders to set new standards for care and service delivery.
Supporting Data and Industry Insights
To fully appreciate the significance of the Hanger Numotion merger, it’s essential to contextualize it within broader industry trends and market data. While the original article doesn’t provide specific financial figures for the transaction or detailed market sizing, general industry insights illuminate the strategic foresight behind this combination.
Market Size and Growth Projections
Industry reports consistently highlight the substantial and growing markets for O&P and CRT. For instance, the global orthotics and prosthetics market has been estimated to be worth tens of billions of dollars annually, with projections indicating a compound annual growth rate (CAGR) in the mid-single digits over the next decade. Similarly, the complex rehabilitation technology and durable medical equipment (DME) market, which includes mobility products, is also a multi-billion dollar sector, driven by increasing prevalence of neurological disorders, spinal cord injuries, and conditions like cerebral palsy and multiple sclerosis.
The North American market, in particular, represents a significant portion of these global figures. Demographic shifts, such as the aging Baby Boomer generation, are contributing to a rising demand for solutions that maintain mobility and independence. Chronic conditions requiring long-term O&P or CRT support are also on the rise, including diabetes-related amputations, osteoarthritis, and various neuromuscular diseases. These demographic and epidemiological drivers create a robust and sustainable growth environment for providers of rehabilitative care. The combined Hanger Numotion, by consolidating market share and diversifying its service portfolio, is strategically positioned to capture a larger portion of this expanding market.
The Value Proposition of Integrated Care
The merger also strongly aligns with the evolving healthcare paradigm that emphasizes integrated care models. Traditional healthcare often operates in silos, where patients must navigate multiple providers and systems for different aspects of their care. This can lead to fragmented services, communication breakdowns, and suboptimal patient outcomes. Integrated care, by contrast, aims to coordinate services across various disciplines, ensuring a holistic and patient-centered approach.
For Hanger Numotion, this means offering a more seamless patient journey. A patient might receive a custom prosthetic from Hanger and then be seamlessly referred within the same organization for a complex power wheelchair from Numotion, with shared patient records and coordinated care plans. This integration is expected to lead to several benefits:
- Improved Patient Outcomes: Coordinated care can result in more effective treatment plans, better adherence, and ultimately, greater functional independence and quality of life.
- Enhanced Patient Experience: Streamlined processes, reduced administrative burden, and a single point of contact for diverse needs can significantly improve patient satisfaction.
- Operational Efficiencies: Integration can lead to economies of scale in areas such as supply chain management, administrative functions, and technology infrastructure, potentially reducing costs and improving service delivery.
- Payer Benefits: Healthcare payers (insurance companies, government programs) are increasingly seeking value-based care models that demonstrate improved outcomes at controlled costs. An integrated provider like Hanger Numotion, with its ability to manage a broader spectrum of patient needs, may be better positioned to demonstrate such value.
Official Responses and Stakeholder Perspectives
The announcement of the Hanger Numotion merger has elicited responses from key executives and financial stakeholders, shedding light on the strategic alignment and future aspirations of the combined entity.
Executive Commentary: A Shared Vision
Mike Swinford’s statement, highlighting the shared "fundamental belief in the role mobility can play in improving people’s lives," underscores a deep philosophical alignment between Hanger and Numotion. This is more than just a business transaction; it’s presented as a union driven by a common purpose to enhance patient independence. His emphasis on building on each company’s strengths suggests a strategy of leveraging existing expertise rather than a complete overhaul, aiming for an additive rather than a disruptive integration.
Pete Stoy’s remarks about Hanger’s transformation under his leadership and his confidence in Swinford provide a clear picture of a well-managed transition. His acknowledgment of Hanger’s investment in "people, technology, and capabilities" aligns perfectly with the stated goals of the combined entity – to expand access, invest in clinicians, and drive innovation. This mutual respect and shared strategic outlook from both leaders are critical for a successful integration.
The Role of Financial Sponsors
The involvement of Patient Square Capital as the controlling entity of the combined company is highly significant. Patient Square Capital is known for its focus on healthcare investments, typically partnering with management teams to build companies that improve patient outcomes and reduce healthcare costs. Their control signals a long-term strategic investment aimed at maximizing the potential of this integrated platform. Their expertise in the healthcare sector will likely provide strategic guidance and capital to support the growth and innovation initiatives of Hanger Numotion.
AEA Investors, as Numotion’s portfolio company, will be exiting their investment as part of this transaction. Private equity firms typically invest for a period with the goal of growing the company and then realizing a return through a sale or IPO. Numotion’s acquisition by Hanger, facilitated by AEA, represents a successful outcome for their investment strategy. Similarly, LLR’s "longstanding investment" in Numotion indicates their belief in the company’s value, and their support through this transition underscores their commitment to its continued success. The involvement of these sophisticated financial sponsors speaks to the underlying financial health and growth prospects of both Hanger and Numotion, and the perceived value of their combination.
Patient and Clinician Impact
For patients, the merger holds the promise of a more seamless and comprehensive care experience. Instead of navigating separate providers for O&P and CRT needs, patients may benefit from integrated assessments, shared care plans, and coordinated service delivery, potentially reducing logistical burdens and improving continuity of care. The expanded scale and resources are also expected to drive innovation, leading to better products and services over time.
For clinicians, the combination could offer enhanced professional development opportunities, access to a broader network of peers for collaboration, and potentially more robust resources for clinical research and technology adoption. The commitment to "invest in clinicians" suggests that Hanger Numotion aims to be an employer of choice in the rehabilitative care sector, attracting and retaining top talent. However, as with any large merger, there will be a period of adjustment, and ensuring that the integration maintains a focus on local patient needs and preserves the unique cultures of the respective clinical teams will be crucial.
Implications for the Future of Rehabilitation and Mobility
The formation of Hanger Numotion represents more than just a large-scale merger; it is a transformative event with far-reaching implications for the future of rehabilitation and mobility services in North America.
A New Benchmark for Integrated Care
This strategic combination is poised to set a new benchmark for integrated care in the O&P and CRT sectors. By bringing together two distinct yet complementary service lines under a unified platform, Hanger Numotion can demonstrate the tangible benefits of a holistic approach to mobility solutions. This could influence other providers in the industry to consider similar integration strategies, either through mergers and acquisitions or through enhanced partnerships. The focus on a complete patient journey, from initial assessment through custom device fitting to ongoing complex rehabilitation and mobility support, offers a compelling model for comprehensive care delivery. This could accelerate a broader industry shift away from siloed services towards more patient-centric, integrated solutions.
Operational Synergies and Challenges
While the strategic advantages are clear, the operational integration of two large organizations like Hanger and Numotion will present significant challenges. Despite the intention to maintain existing brands and clinical operations, achieving true operational synergies will require careful planning and execution. This includes harmonizing IT systems, integrating supply chains for efficiency, standardizing best practices across clinics, and fostering a cohesive corporate culture across diverse teams. Effective communication and change management will be paramount to ensure that the transition is smooth for employees and that patient care remains uninterrupted and of the highest quality. Navigating potential regulatory hurdles, particularly concerning antitrust laws for a transaction of this size, will also be a critical aspect of the extended closing period.
Long-Term Outlook and Market Leadership
With its expanded footprint, diversified service offerings, and significant resources, Hanger Numotion is exceptionally well-positioned to become the dominant leader in the North American rehabilitative and mobility solutions market. The long-term outlook involves not only capitalizing on the organic growth of the O&P and CRT markets but also potentially pursuing further strategic acquisitions to expand into new geographies or specialized service areas. The ability to invest in advanced technologies, conduct extensive research, and develop innovative patient solutions will likely solidify its market leadership. By setting high standards for clinical excellence, patient experience, and operational efficiency, Hanger Numotion has the potential to redefine expectations for quality and service delivery across the entire industry. Its influence could extend to shaping policy discussions, advocating for patient access, and driving advancements in the field of rehabilitative medicine.
Conclusion: A Transformative Step Forward
The impending merger of Hanger and Numotion to form Hanger Numotion is a truly transformative development for the rehabilitative care industry. It represents a bold strategic vision to create a comprehensive, patient-centered platform that addresses a wide spectrum of mobility needs across North America. By combining Hanger’s deep expertise in orthotics and prosthetics with Numotion’s leadership in complex rehabilitation technology, the new entity promises to deliver enhanced access to care, foster groundbreaking innovation, and make substantial investments in the clinical professionals who are at the heart of patient well-being.
With seasoned leadership under Mike Swinford, the backing of Patient Square Capital, and a shared commitment to improving lives through mobility, Hanger Numotion is poised to not only achieve significant business growth but also to fundamentally elevate the standard of care for millions of patients. As the transaction moves towards its anticipated close in late 2026, the industry will be watching closely to see how this new powerhouse reshapes the future of rehabilitation and mobility, marking a pivotal moment in the journey towards greater independence and improved quality of life for individuals across the continent.
